120 related articles for article (PubMed ID: 9317154)
1. The role of IFN regulatory factor-1 in synovitis and nitric oxide production.
Shiraishi A; Dudler J; Lotz M
J Immunol; 1997 Oct; 159(7):3549-54. PubMed ID: 9317154
[TBL] [Abstract][Full Text] [Related]
2. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes.
Salkowski CA; Barber SA; Detore GR; Vogel SN
J Immunol; 1996 May; 156(9):3107-10. PubMed ID: 8617930
[TBL] [Abstract][Full Text] [Related]
3. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice.
Salkowski CA; Kopydlowski K; Blanco J; Cody MJ; McNally R; Vogel SN
J Immunol; 1999 Aug; 163(3):1529-36. PubMed ID: 10415056
[TBL] [Abstract][Full Text] [Related]
4. Frontline: interferon regulatory factor-1 as a protective gene in intestinal inflammation: role of TCR gamma delta T cells and interleukin-18-binding protein.
Siegmund B; Sennello JA; Lehr HA; Senaldi G; Dinarello CA; Fantuzzi G
Eur J Immunol; 2004 Sep; 34(9):2356-64. PubMed ID: 15307168
[TBL] [Abstract][Full Text] [Related]
5. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
6. Requirement for STAT1 in LPS-induced gene expression in macrophages.
Ohmori Y; Hamilton TA
J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
[TBL] [Abstract][Full Text] [Related]
7. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice.
Khan IA; Matsuura T; Fonseka S; Kasper LH
J Immunol; 1996 Jan; 156(2):636-43. PubMed ID: 8543815
[TBL] [Abstract][Full Text] [Related]
8. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
9. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharide-induced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene.
Gao JJ; Filla MB; Fultz MJ; Vogel SN; Russell SW; Murphy WJ
J Immunol; 1998 Nov; 161(9):4803-10. PubMed ID: 9794412
[TBL] [Abstract][Full Text] [Related]
10. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Grieder FB; Vogel SN
Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
12. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
[TBL] [Abstract][Full Text] [Related]
13. KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
Inoue T; Hamada Y; Takeshita K; Fukushima K; Higaki M
J Rheumatol; 2001 Jun; 28(6):1229-37. PubMed ID: 11409114
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
15. 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.
Lee SH; Nishino M; Mazumdar T; Garcia GE; Galfione M; Lee FL; Lee CL; Liang A; Kim J; Feng L; Eissa NT; Lin SH; Yu-Lee LY
Cancer Res; 2005 Sep; 65(17):7984-92. PubMed ID: 16140971
[TBL] [Abstract][Full Text] [Related]
16. Interferon (IFN)-gamma and Herpes simplex virus/tumor necrosis factor-alpha synergistically induce nitric oxide synthase 2 in macrophages through cooperative action of nuclear factor-kappa B and IFN regulatory factor-1.
Paludan SR; Malmgaard L; Ellermann-Eriksen S; Boscá L; Mogensen SC
Eur Cytokine Netw; 2001; 12(2):297-308. PubMed ID: 11399519
[TBL] [Abstract][Full Text] [Related]
17. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
18. Impaired IFN-gamma production in IFN regulatory factor-1 knockout mice during endotoxemia is secondary to a loss of both IL-12 and IL-12 receptor expression.
Salkowski CA; Thomas KE; Cody MJ; Vogel SN
J Immunol; 2000 Oct; 165(7):3970-7. PubMed ID: 11034406
[TBL] [Abstract][Full Text] [Related]
19. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis.
Tendler DS; Bao C; Wang T; Huang EL; Ratovitski EA; Pardoll DA; Lowenstein CJ
Cancer Res; 2001 May; 61(9):3682-8. PubMed ID: 11325839
[TBL] [Abstract][Full Text] [Related]
20. STAT1 is required for iNOS activation, but not IL-6 production in murine fibroblasts.
Samardzic T; Jankovic V; Stosic-Grujicic S; Trajkovic V
Cytokine; 2001 Feb; 13(3):179-82. PubMed ID: 11161462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
